These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Post-transplantation osteoporosis. Stein E; Ebeling P; Shane E Endocrinol Metab Clin North Am; 2007 Dec; 36(4):937-63; viii. PubMed ID: 17983930 [TBL] [Abstract][Full Text] [Related]
4. Markers of bone metabolism in eugonadal female patients with beta-thalassemia major. Angelopoulos NG; Goula A; Katounda E; Rombopoulos G; Kaltzidou V; Kaltsas D; Konstandelou E; Tolis G Pediatr Hematol Oncol; 2007; 24(7):481-91. PubMed ID: 17786784 [TBL] [Abstract][Full Text] [Related]
5. Unexpected low incidence of vertebral fractures in heart transplant recipients: analysis of bone turnover. Kerschan-Schindl K; Ruzicka M; Mahr S; Paireder M; Krestan C; Gleiss A; Bieglmayer C; Fialka-Moser V; Pacher R; Grimm M; Pietschmann P Transpl Int; 2008 Mar; 21(3):255-62. PubMed ID: 18039318 [TBL] [Abstract][Full Text] [Related]
6. Markers of bone turnover: consideration on their clinical application in osteoporosis. Cantatore FP; Pipitone V Panminerva Med; 1999 Sep; 41(3):247-51. PubMed ID: 10568124 [TBL] [Abstract][Full Text] [Related]
7. Impact of calcineurin inhibitors on bone metabolism in primary kidney transplant patients. Bozkaya G; Nart A; Uslu A; Onman T; Aykas A; Doğan M; Karaca B Transplant Proc; 2008; 40(1):151-5. PubMed ID: 18261573 [TBL] [Abstract][Full Text] [Related]
8. Strategies to manage the heart failure patient after transplantation. Mudge GH Clin Cardiol; 1992 Sep; 15 Suppl 1():I37-41. PubMed ID: 1395214 [TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of bone loss in heart transplant candidates and recipients. Kerschan-Schindl K; Strametz-Juranek J; Heinze G; Grampp S; Bieglmayer C; Pacher R; Maurer G; Fialka-Moser V; Pietschmann P J Heart Lung Transplant; 2003 Aug; 22(8):843-50. PubMed ID: 12909462 [TBL] [Abstract][Full Text] [Related]
10. Hyperhomocysteinemia--the biochemical link between a weak heart and brittle bones? Herrmann M; Taban-Shomal O; Müller S; Gunter L; Hübner U; Böhm M; Herrmann W Clin Lab; 2006; 52(3-4):137-47. PubMed ID: 16584060 [TBL] [Abstract][Full Text] [Related]
11. The use of biochemical markers of bone turnover in osteoporosis. Allende-Vigo MZ P R Health Sci J; 2007 Jun; 26(2):91-5. PubMed ID: 17722420 [TBL] [Abstract][Full Text] [Related]
12. Systemic assessments utilizing saliva: part 2 osteoporosis and use of saliva to measure bone turnover. Koka S; Forde MD; Khosla S Int J Prosthodont; 2006; 19(1):53-60. PubMed ID: 16479761 [TBL] [Abstract][Full Text] [Related]
13. Does homocysteine contribute to bone disease in hyperparathyroidism? Alley RA; Chen EL; Beyer TD; Prinz RA Am J Surg; 2008 Mar; 195(3):374-7; discussion 377-8. PubMed ID: 18222411 [TBL] [Abstract][Full Text] [Related]
14. [Congestive heart failure in childhood. An epidemiologic study]. Sommers C; Nagel BH; Neudorf U; Schmaltz AA Herz; 2005 Nov; 30(7):652-62. PubMed ID: 16333593 [TBL] [Abstract][Full Text] [Related]
16. Phenotypic assessment of endothelial microparticles in patients with heart failure and after heart transplantation: switch from cell activation to apoptosis. Garcia S; Chirinos J; Jimenez J; Del Carpio Muñoz F; Canoniero M; Jy W; Jimenez J; Horstman L; Ahn Y J Heart Lung Transplant; 2005 Dec; 24(12):2184-9. PubMed ID: 16364869 [TBL] [Abstract][Full Text] [Related]
17. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670 [TBL] [Abstract][Full Text] [Related]
18. [Biochemical markers of bone formation in hemodialysis and after allotransplantation of cadaveric kidney]. Ermakova IP; Pronchenko IA; Buzulina VP; Nikonova TIu; Borisova AV Ter Arkh; 2006; 78(10):73-6. PubMed ID: 17180944 [TBL] [Abstract][Full Text] [Related]
19. Bone fractures after cardiac transplantation. Luaces M; Crespo Leiro MG; Paniagua Martin MJ; de Lara JG; Rivas RM; Piñon Esteban P; Cursak G; Ríos R; Leira CN; Alonso JJ; Beiras AC Transplant Proc; 2007 Sep; 39(7):2393-6. PubMed ID: 17889200 [TBL] [Abstract][Full Text] [Related]
20. Changes in the serum sex steroids, IL-7 and RANKL-OPG system after bone marrow transplantation: influences on bone and mineral metabolism. Baek KH; Oh KW; Lee WY; Tae HJ; Rhee EJ; Han JH; Cha BY; Kim YJ; Lee KW; Son HY; Kang SK; Kim CC; Kang MI Bone; 2006 Dec; 39(6):1352-60. PubMed ID: 16905375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]